趋化因子受体的结构与信号转导机制

doi:10.3969/j.issn.0253-9608.2021.01.003

摘要/Abstract

摘要： 趋化因子（chemokine）及趋化因子受体（chemokine receptor）在介导细胞迁移、增殖和抵御病原体入侵过程中发挥重要作用，并且与免疫环境中炎症和癌症的发生发展密切相关。人体中有20多种趋化因子受体和近50种趋化因子。一种趋化因子可以结合多种受体，反之亦然，它们相互作用构成了复杂的趋化因子调控网络。对趋化因子及其受体的三维结构的解析，对于我们更深入理解趋化因子受体家族的激活机制与药理功能具有非常重要的意义。文章总结了已解析的与内源性趋化因子配体或其类似物结合的趋化因子受体结构，分析了趋化因子激活相应趋化因子受体的分子机制，以及对于抗癌药物开发设计的重要性。

关键词: , G蛋白偶联受体；趋化因子；趋化因子受体；激活机制；结构生物学

Abstract: Chemokine and chemokine receptor play important roles in cell migration, proliferation and resisting invasion, thus closely related with multiple fundamental biological processes and disease development in immune environment, such as inflammation and cancer. There are more than 20 different chemokine receptors and nearly 50 chemokines in human body. One chemokine can bind multiple receptors and vice versa. Their interaction forms a complex chemokine regulatory network. Analysis of the three-dimensional structures of chemokines and their receptors will further improve our understanding of the activation mechanism and pharmacological functions of the chemokine receptor family. Here, we briefly review the solved structure of chemokine receptors bound with chemokine ligands or their analogs, and analyze the structure and activation mechanism of chemokine receptors, and indicate the importance of the anticancer drug development of chemokine receptor family.

刘凯雯, 刘志杰, 华甜. 趋化因子受体的结构与信号转导机制[J]. 自然杂志, 2021, 43(1): 18-24.

LIU Kaiwen, LIU Zhijie, HUA Tian. Structural and signaling mechanism of chemokine receptors[J]. Chinese Journal of Nature, 2021, 43(1): 18-24.

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.nature.shu.edu.cn/CN/10.3969/j.issn.0253-9608.2021.01.003

https://www.nature.shu.edu.cn/CN/Y2021/V43/I1/18

[1] PIERCE K L, PREMONT R T, LEFKOWITZ R J. Seventransmembrane receptors [J]. Nat Rev Mol Cell Biol, 2002, 3(9): 639-650. [2] HAUSER A S, ATTWOOD M M, RASK-ANDERSEN M, et al. Trends in GPCR drug discovery: new agents, targets and indications [J]. Nat Rev Drug Discov, 2017, 16(12): 829-842.

[3] MANTOVANI A, SAVINO B, LOCATI M, et al. The chemokine system in cancer biology and therapy [J]. Cytokine Growth Factor Rev, 2010, 21(1): 27-39.

[4] LE Y, ZHOU Y, IRIBARREN P, et al. Chemokines and chemokine receptors: their manifold roles in homeostasis and disease [J]. Cell Mol Immunol, 2004, 1(2): 95-104.

[5] BIZZARRI C, BECCARI A R, BERTINI R, et al. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets [J]. Pharmacol Ther, 2006, 112(1): 139-149.

[6] ROLLINS B J. Chemokines [J]. Blood, 1997, 90(3): 909-928.

[7] BAGGIOLINI M. Chemokines and leukocyte traffic [J]. Nature, 1998, 392(6676): 565-568.

[8] GUO F, LONG L, WANG J, et al. Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy [J]. Oncol Lett, 2019, 18(6): 5699-5708.

[9] QIN L, KUFAREVA I, HOLDEN LG, et al. Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine [J]. Science, 2015, 347(6226): 1117-1122.

[10] BURG J S, INGRAM J R, VENKATAKRISHNAN A J, et al. Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor [J]. Science, 2015, 347(6226): 1113-1117.

[11] ZHENG Y, HAN G W, ABAGYAN R, et al. Structure of CC chemokine receptor 5 with a potent chemokine antagonist reveals mechanisms of chemokine recognition and molecular mimicry by HIV [J]. Immunity, 2017, 46(6): 1005-1017. e5.

[12] WASILKO D J, JOHNSON Z L, AMMIRATI M, et al. Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20 [J]. Nat Commun, 2020, 11(1): 3031.

[13] LIU K, WU L, YUAN S, et al. Structural basis of CXC chemokine receptor 2 activation and signalling [J]. Nature, 2020, 585(7823): 135-140.

[14] WU B, CHIEN E Y, MOL C D, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists [J]. Science, 2010, 330(6007): 1066-1071.

[15] TAN Q, ZHU Y, LI J, et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex [J]. Science, 2013, 341(6152): 1387-1390.

[16] OSWALD C, RAPPAS M, KEAN J, et al. Intracellular allosteric antagonism of the CCR9 receptor [J]. Nature, 2016, 540(7633): 462-465.

[17] ZHENG Y, QIN L, ZACARIAS N V, et al. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists [J]. Nature, 2016, 540(7633): 458-461.

[18] JAEGER K, BRUENLE S, WEINERT T, et al. Structural basis for allosteric ligand recognition in the human CC chemokine receptor 7 [J]. Cell, 2019, 178(5): 1222-1230. e10.

[19] KLEIST A B, GETSCHMAN A E, ZIAREK J J, et al. New paradigms in chemokine receptor signal transduction: moving beyond the two-site model [J]. Biochem Pharmacol, 2016, 114: 53- 68.

[20] SCHOLTEN D J, CANALS M, MAUSSANG D, et al. Pharmacological modulation of chemokine receptor function [J]. Br J Pharmacol, 2012, 165(6): 1617-1643.

[21] CRUMP M P, GONG J H, LOETSCHER P, et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 [J]. EMBO J, 1997, 16(23): 6996-7007.

[22] PRADO G N, SUETOMI K, SHUMATE D, et al. Chemokine signaling specificity: Essential role for the N-terminal domain of chemokine receptors [J]. Biochemistry, 2007, 46(31): 8961-8968.

[23] ROUMEN L, SCHOLTEN D J, DE KRUIJF P, et al. C(X)CR in silico: Computer-aided prediction of chemokine receptor-ligand interactions [J]. Drug Discov Today Technol, 2012, 9(4): e281-291.

[24] KOEHL A, HU H, MAEDA S, et al. Structure of the micro-opioid receptor-Gi protein complex [J]. Nature, 2018, 558(7711): 547-552.

[25] GARCIA-NAFRIA J, NEHME R, EDWARDS P C, et al. Cryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go [J]. Nature, 2018, 558(7711): 620-623.

[26] DRAPER-JOYCE C J, KHOSHOUEI M, THAL D M, et al. Structure of the adenosine-bound human adenosine A1 receptor-Gi complex [J]. Nature, 2018, 558(7711): 559-563.

[27] MAEDA S, QU Q, ROBERTSON M J, et al. Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes [J]. Science, 2019, 364(6440): 552-557.

[28] HUA T, LI X, WU L, et al. Activation and signaling mechanism revealed by cannabinoid receptor-Gi complex structures [J]. Cell, 2020, 180(4): 655-665. e18.

[29] KRISHNA KUMAR K, SHALEV-BENAMI M, ROBERTSON M J, et al. Structure of a signaling cannabinoid receptor 1-G protein complex [J]. Cell, 2019, 176(3): 448-458. e12.

[30] XING C, ZHUANG Y, XU T H, et al. Cryo-EM Structure of the human cannabinoid receptor CB2-Gi signaling complex [J]. Cell, 2020, 180(4): 645-654. e13.

[31] RASMUSSEN S G F, DEVREE B T, ZOU Y, et al. Crystal structure of the β2 adrenergic receptor-Gs protein complex [J]. Nature, 2011, 477(7366): 549-555.

[32] MURPHY P M, TIFFANY H L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science. 1991. 253: 1280-1283 [J]. J Immunol, 2009, 183(5): 2898-2901.

[33] NASSER M W, RAGHUWANSHI S K, GRANT D J, et al. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer [J]. J Immunol, 2009, 183(5): 3425- 3432.

趋化因子受体的结构与信号转导机制

Structural and signaling mechanism of chemokine receptors

PDF

可视化

摘要/Abstract

引用本文

使用本文

相关文章 15

编辑推荐

Metrics

本文评价

[1]	向阳建, 邹何, 徐波, 魏云林. 弱毒真菌病毒在植物病害防治中的应用潜力[J]. 自然杂志, 2025, 47(5): 412-418.
[2]	姜利海, 刘培荣, 王志浩, 巫金波. 电驱动智能窗[J]. 自然杂志, 2025, 47(4): 281-288.
[3]	蒋如斌, 刘冬霞, 袁善锋, 张鸿波, 吴学珂. 雷暴电学与人工引雷[J]. 自然杂志, 2025, 47(4): 249-260.
[4]	张文霞, 俞妍, 桂可心, 周天军. 气候变化与野火[J]. 自然杂志, 2025, 47(4): 261-269.
[5]	王云鹤, 李哲涵, 邓书金, 武海斌. 基于光栅芯片的冷原子真空计量[J]. 自然杂志, 2025, 47(4): 289-293.
[6]	付勇搏, 向慧静. 癌症光疗的新纪元：发展、机制和应用[J]. 自然杂志, 2025, 47(3): 190-195.
[7]	冀婧文, 钟俊杰, 钮冰, 陈沁. 图像识别模型在野生动物保护中的应用[J]. 自然杂志, 2025, 47(3): 207-214.
[8]	钱丽嘉, 沈博宇, 郑雨轩, 蒋怿越, 陶鹏杰, 吕东潮. RNA治疗的应用及挑战[J]. 自然杂志, 2025, 47(3): 233-238.
[9]	夏丽丽, 吴陈瑶, 冯炜, 陈雨. 生物催化材料：泛催化精准医疗的“工具箱”[J]. 自然杂志, 2025, 47(3): 183-189.
[10]	赵葛剑, 张新鹏. DeepSeek：从“概率生成”到“因果推理”[J]. 自然杂志, 2025, 47(2): 79-84.
[11]	王邓, 韩健, 郭俊锋, 强亚琴. 寒武纪大爆发期间蜕皮动物躯体构型起源与演化[J]. 自然杂志, 2025, 47(2): 125-133.
[12]	张志飞, 胡亚洲, 梁悦, 刘璠, 罗梅, 张彩彬, 王棹. 寒武纪大爆发组织拼图假说与地球后生动物门类起源[J]. 自然杂志, 2025, 47(2): 95-115.
[13]	郭晓强, 李岩异. RNA研发简史：从微不足道到无比重要[J]. 自然杂志, 2022, 44(6): 480-490.
[14]	赵飞燕, 吴宇轩. 胎儿血红蛋白再生治疗β-血红蛋白病[J]. 自然杂志, 2022, 44(5): 389-397.
[15]	何韫荃, 郭阶雨, 魏香香, 孟丹. 转录因子BACH1的研究进展[J]. 自然杂志, 2022, 44(2): 79-86.